Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: CT/ It's about info on the agreement with Dominion

It is called a Shareholder Derivative Action. If memory serves me correctly, it has been discussed on here many times.

As for the strategy behind the confidentiality, we signed them and they work for us. Our POS BOD must have had their reasons (right).

Share
New Message
Please login to post a reply